In this podcast, Robert S. Rosenson, MD, from the Icahn School of Medicine at Mount Sinai in New York, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease...
In this commentary, a team from Johns Hopkins Medicine writes about their experiences creating and implementing a digital health platform and explains how apps can contribute to improving patients’ health.
...
She talks about her research that examined the relative strength of associations between region, hospital, and patient characteristics with high-intensity statin use after myocardial...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
The STURDY study recently evaluated how OH timing is associated with dizziness in older patients. Coauthor Stephen P. Juraschek, MD, PhD, discusses these findings and how they compare with past...
In this editorial by Consultant Board Member Dr Michael Bloch, he reflects on a 1961 Consultant article about cardiovascular disease management and how it has affected him.
A recent study highlighted a link between the use of fluoroquinolones, a commonly prescribed class of antibiotic, and the risk of aortic and mitral regurgitation. Consultant360 spoke with Mahyar Etminan,...
